Our complementary asset classes offer a unique investment platform.

TPG Capital is TPG's principal investment platform in the U.S., Europe, Asia, Australia and Latin America, and generally focuses on established businesses that require equity capital between $10 million and $1 billion. Investments in companies through acquisitions and restructurings span a broad range of industries including financial services, travel and entertainment, technology, retail, consumer products, healthcare, and media and communications. TPG Capital has had lead responsibility for more than 140 transactions, investing approximately $31.1 billion of equity capital across a number of economic and credit cycles.

TPG Growth is TPG's platform for smaller buyouts and growth equity investments globally. TPG Growth invests in a broad range of industries including consumer, retail, technology, internet, healthcare, energy, cleantech and renewables, transportation, industrials, and business services.  TPG Growth utilizes a broad range of investment structures including leverage buyouts, growth equity, and private investment in public equities (PIPE's), and leverages the broader platform of TPG Capital.

TPG Biotech is TPG's life science venture capital platform, supporting physicians, scientists and entrepreneurs who are building innovation-based businesses.

TPG Alternative & Renewable Technologies (TPG “ART”) is TPG’s platform dedicated to developing and deploying alternative and renewable technologies.

TPG Special Situations ("TSSP") is TPG’s special situations and credit platform and encompasses TPG Opportunities Partners, TPG Specialty Lending, Inc., and TPG Institutional Credit Partners.

TPG Opportunities Partners ("TOP") is TPG's platform for pursuing actively managed global special situations and opportunistic credit investments. TOP seeks to purchase or originate special situations/distressed investments across the credit cycle by targeting deep value opportunities that are difficult to source, analyze, or execute.

TPG Specialty Lending, Inc. (NYSE: TSLX, “TSL”) is a specialty finance company focused on lending to middle-market companies. TSL seeks to generate current income primarily in U.S.-domiciled middle-market companies through direct originations of senior secured loans and, to a lesser extent, originations of mezzanine loans and investments in corporate bonds and equity securities. TSL has elected to be regulated as a business development company, or a BDC, under the Investment Company Act of 1940 and the rules and regulations promulgated thereunder.

TPG Institutional Credit ("TICP") is TPG’s platform for collateralized loan obligations (CLOs), which is managed through the TSSP platform.  TICP invests in institutional, liquid credit products, primarily in structured funds.

Click here for information on certain other strategic relationships.